RxDoctor Payments Data

Derek Klavas, MD

Foot and Ankle Surgery · Mobile, ALNPI 1013361823

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 49.0% of the total. Reporting peaked in 2022 at $5,650 and has fallen 59.5% since, to $2,287 in 2025.

$11,655in general payments, 2019–2025

Across 128 payments — averaging $91.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Arthrex$4K
  • Medical Device Business Services, Inc.$916
  • Smith+Nephew$380
  • Johnson & Johnson$264
  • Paragon 28, Inc.$231
  • plus $641 from 12 others

What the payments were for

  • Travel & lodging$4,33937%
  • Food & beverage$4,91542%
  • Education$2,40021%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,655 in reported general payments places this provider in the 75th percentile of 40 foot and ankle surgery providers in Alabama.

See all foot and ankle surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$118,771
Medicare patients
289
Services billed
1,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen76$622
Ondansetron OdtOndansetron35$584
Diclofenac Sodium22$470
Doxycycline Hyclate26$360
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$275
Meloxicam97$254
Acetaminophen-CodeineAcetaminophen With Codeine24$226
Methylprednisolone18$172
Tramadol Hcl35$163
Gabapentin19$145
Clindamycin Hcl15$117
Cephalexin35$102
Colchicine13$75

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →